Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.45 |
| ▸ | PTPRF | P10586 | 1/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | NSD2 | O96028 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29457964 | 1.00 | MEN1 (0.55) | MEN1KMT2ATDP1PBRM1PTPRF | |
| SCHEMBL27796513 | 0.84 | MEN1 (0.47) | MEN1KMT2ATDP1PBRM1PTPRF | |
| SCHEMBL6061552 | 0.81 | THRB (0.43) | MEN1KMT2ATDP1PBRM1ALDH1A1 | |
| SCHEMBL14237092 | 0.81 | CES2 (0.48) | MEN1KMT2ATDP1PTPRFPTPN2 | |
| SCHEMBL28879922 | 0.81 | KMT2A (0.42) | MEN1KMT2ATDP1PBRM1ALDH1A1 | |
| SCHEMBL279655 | 0.81 | ALDH1A1 (0.53) | MEN1KMT2ATDP1PBRM1ALDH1A1 | |
| Acetic Acid SCHEMBL28541591 | 0.79 | ALDH1A1 (0.54) | MEN1KMT2ATDP1ALDH1A1KDM4E | |
| SCHEMBL19834671 | 0.79 | BRPF1 (0.42) | MEN1KMT2ATDP1PBRM1ALDH1A1 | |
| SCHEMBL29978292 | 0.79 | THRB (0.46) | MEN1KMT2ATDP1PBRM1ALDH1A1 | |
| SCHEMBL1374423 | 0.79 | THRB (0.46) | MEN1KMT2ATDP1PBRM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115925527-A | Method for preparing alpha-diaryl methyl substituted ketone compound | 湖南理工学院 | 2023-04-07 | — | — | CN | claimed |
| US-9174906-B2 | Process for producing optically active secondary alcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2015-11-03 | — | — | US | claimed |
| CN-100595194-C | Method for preparing N-hydroxyamber imide ester by acetyliode-benzoic alcohot oxide | DALIAN CHEMICAL PHYSICS INST | 2010-03-24 | — | — | CN | claimed |
| CN-101045703-A | Method for preparing N-hydroxyamber imide ester by acetyliode-benzoic alcohot oxide | DALIAN CHEMICAL PHYSICS INST (CN) | 2007-10-03 | — | — | CN | claimed |
| CN-116813686-B | Asymmetric synthesis method and application of 7-oxo-resorcinol lactone | 欣凯医药化工中间体（上海）有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4581071-A1 | METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE | Forschungszentrum Jülich GmbH (DE) | 2025-07-09 | — | — | EP | disclosed |
| WO-2025084341-A1 | IODINE-CONTAINING (METH)ACRYLATE COMPOUND, IODINE-CONTAINING (METH)ACRYLATE (CO)POLYMER, LITHOGRAPHY COMPOSITION, RESIST COMPOSITION, UNDERLAYER FILM-FORMING COMPOSITION, AND METHOD FOR PRODUCING IODINE-CONTAINING (METH)ACRYLATE COMPOUND | 三菱瓦斯化学株式会社 | 2025-04-24 | — | — | WO | disclosed |
| US-20250034110-A1 | LPAR1 ANTAGONISTS AND USES THEREOF | Pipeline Therapeutics, Inc. | 2025-01-30 | — | — | US | disclosed |
| US-12187681-B2 | Ion channel antagonists/blockers and uses thereof | SHANGHAI EAST HOSPITAL (CN) | 2025-01-07 | — | — | US | disclosed |
| CN-115286573-B | Green synthesis method of 1-alkoxyisoquinoline compound | 常州工程职业技术学院 | 2024-12-10 | — | — | CN | disclosed |
| US-20240166679-A1 | USE OF KETOACIDS FOR LIGNIN STABILIZATION DURING EXTRACTION FROM LIGNOCELLULOSIC BIOMASS | LYGG CORPORATION | 2024-05-23 | — | — | US | disclosed |
| CN-118043041-A | LPAR1 antagonists and uses thereof | 康蒂内乌姆医疗公司 | 2024-05-14 | — | — | CN | disclosed |
| EP-1215208-A2 | 4-Aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases | Agouron Pharmaceuticals, Inc. (US) | 2002-06-19 | — | — | EP | disclosed |
| US-20020049251-A1 | Methods for treating cell death diseases and inflammation | HARVARD COLLEGE, PRESIDENT AND FELLOWS | 2002-04-25 | — | — | US | disclosed |
| WO-2001041709-A2 | METHODS FOR TREATING CELL DEATH DISEASES AND INFLAMMATION | PRESIDENT AND FELLOWS OF HARWARD COLLEGE (US) | 2001-06-14 | — | — | WO | disclosed |
| EP-1056732-A2 | 4-AMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASES | AGOURON PHARMACEUTICALS, INC. (US) | 2000-12-06 | — | — | EP | disclosed |
| WO-1999021845-A2 | 4-AMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASES | AGOURON PHARMACEUTICALS, INC. (US) | 1999-05-06 | — | — | WO | disclosed |
| EP-0569409-A1 | AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE | THE WELLCOME FOUNDATION LIMITED (GB) | 1993-11-18 | — | — | EP | disclosed |
| WO-1992012959-A1 | AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-08-06 | — | — | WO | disclosed |
| CN-1043929-A | The method of dehydrohalogenating aromatic halides | EASTMAN KODAK CO (US) | 1990-07-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166679-A1 | USE OF KETOACIDS FOR LIGNIN STABILIZATION DURING EXTRACTION FROM LIGNOCELLULOSIC BIOMASS | KHK, LCT, HOGA1 | MEN1 4749/4885KMT2A 386/4885TDP1 3442/4885 |
| US-20250034110-A1 | LPAR1 ANTAGONISTS AND USES THEREOF | LPAR1, LPAR2, LPAR3 | MEN1 2811/4885KMT2A 2605/4885TDP1 3301/4885 |
| US-20020049251-A1 | Methods for treating cell death diseases and inflammation | CASP3, CASP9, CASP2 | MEN1 3764/4885KMT2A 4228/4885TDP1 2755/4885 |
| US-12187681-B2 | Ion channel antagonists/blockers and uses thereof | CACNA1F, CACNA1S, CACNA1D | MEN1 2638/4885KMT2A 3777/4885TDP1 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.